Human Gene Therapy Experiments

NIH Advisory Panel Doesn't Vote on Moratorium Proposal

Published in Medical Letter on the CDC and FDA, March 27th, 2000

An advisory committee to the U.S. National Institutes of Health debated a proposal calling for a moratorium on human gene therapy experiments, but then adjourned without taking a vote.

The proposal, formally presented to the committee on March 10, 2000, by a Washington activist group, called for a halt to gene therapy experiments except as a "last resort for life threatening illness." The motion by the Foundation of Economic Trends cited the death last fall of a Tucson, Arizona, teenager, along with hundreds of reported adverse reactions among patients enrolled in gene therapy as reasons to "impose an immediate moratorium" on gene therapy experiments.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2000-03-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry